BioWorld Asia

Feb. 28, 2007

Two VC Companies Closing Funds Raising More than $1B

LONDON - Two European venture capital firms announced the closing of new funds, raising €785 million (US$1.03 billion) in total for investment in early stage companies. (BioWorld International) Read More

Algeta Reports Phase II Data For Alpharadin In Prostate Cancer

Gene Variant Halves Risks From A Number Of Infectious Diseases

European Patent On Enzymes Sends Ark Stock To High Point

Tighter Drug Safety Monitoring Rules Are Coming To Europe

Top Europe Research Seeks Clarity on Stem Cell Rules

Genfit Renews Collaborations With Sanofi-Aventis, Solvay

Hybrigenics Refocuses Its Efforts On Ubiquitin-Specific Proteases

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

Alicorn synthesizes new AAK1 inhibitors

BioWorld Science

Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...

UTRN gene involved in arthrogryposis, study finds

BioWorld Science

Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...

Illustration of glucose in the blood stream

CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

BioWorld Science

Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...

GLP-1s need technologies for long-term use

BioWorld

For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...